YU36505B - Process for obtaining morphinone derivatives - Google Patents

Process for obtaining morphinone derivatives

Info

Publication number
YU36505B
YU36505B YU01197/73A YU119773A YU36505B YU 36505 B YU36505 B YU 36505B YU 01197/73 A YU01197/73 A YU 01197/73A YU 119773 A YU119773 A YU 119773A YU 36505 B YU36505 B YU 36505B
Authority
YU
Yugoslavia
Prior art keywords
obtaining
morphinone
derivatives
morphinone derivatives
obtaining morphinone
Prior art date
Application number
YU01197/73A
Other languages
English (en)
Other versions
YU119773A (en
Inventor
Candiac Mnkovic Ivo
Mnkovic Ivo Candiac
Conway Thomas Terry
Thomas Terry Conway
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU119773A publication Critical patent/YU119773A/xx
Publication of YU36505B publication Critical patent/YU36505B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
YU01197/73A 1972-05-10 1973-05-07 Process for obtaining morphinone derivatives YU36505B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25187972A 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
YU119773A YU119773A (en) 1982-02-25
YU36505B true YU36505B (en) 1984-02-29

Family

ID=22953785

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01197/73A YU36505B (en) 1972-05-10 1973-05-07 Process for obtaining morphinone derivatives

Country Status (13)

Country Link
US (1) US3775414A (nl)
JP (1) JPS535672B2 (nl)
CA (1) CA989827A (nl)
CH (1) CH590238A5 (nl)
CS (3) CS178425B2 (nl)
DD (1) DD106841A5 (nl)
DK (1) DK138492B (nl)
HU (2) HU168597B (nl)
IL (1) IL42219A (nl)
NL (1) NL155256B (nl)
OA (1) OA04406A (nl)
SE (2) SE403106B (nl)
YU (1) YU36505B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
NO793297L (no) * 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
NO802139L (no) * 1979-08-09 1981-02-10 Mallinckrodt Inc Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
US5109136A (en) * 1990-08-09 1992-04-28 Warner-Lambert Company Tetracyclic amines useful as cerebrovascular agents
KR102102513B1 (ko) 2014-10-14 2020-04-20 히사미쓰 세이야꾸 가부시키가이샤 첩부제
WO2017168444A1 (en) * 2016-03-29 2017-10-05 Hikal Limited An improved process for the preparation of butorphanol tartrate
JP6865235B2 (ja) 2016-12-28 2021-04-28 久光製薬株式会社 ブトルファノール含有貼付剤
JP6773897B2 (ja) 2017-04-25 2020-10-21 久光製薬株式会社 貼付剤
US11202764B2 (en) 2017-04-25 2021-12-21 Hisamitsu Pharmaceutical Co., Inc. Patch
CN112592342B (zh) * 2021-01-15 2022-02-22 福安药业集团重庆礼邦药物开发有限公司 一种布托啡诺脱环丁基杂质化合物的制备方法

Also Published As

Publication number Publication date
CS178425B2 (nl) 1977-09-15
US3775414A (en) 1973-11-27
SE7604162L (sv) 1976-04-08
CA989827A (en) 1976-05-25
DD106841A5 (nl) 1974-07-05
HU169023B (nl) 1976-09-28
DK138492C (nl) 1979-02-19
OA04406A (fr) 1980-02-29
CH590238A5 (nl) 1977-07-29
NL155256B (nl) 1977-12-15
CS178446B2 (nl) 1977-09-15
DK138492B (da) 1978-09-18
JPS535672B2 (nl) 1978-03-01
YU119773A (en) 1982-02-25
HU168597B (nl) 1976-06-28
SE403106B (sv) 1978-07-31
IL42219A0 (en) 1973-07-30
IL42219A (en) 1977-06-30
JPS4961169A (nl) 1974-06-13
SE411042B (sv) 1979-11-26
CS178447B2 (nl) 1977-09-15
NL7306344A (nl) 1973-11-13

Similar Documents

Publication Publication Date Title
JPS5387385A (en) Process for preparing benzodiazokyne derivative
CS183689B2 (en) Process for preparing pyridylphenoxyalkane derivatives
YU42539B (en) Process for obtaining alkanolamine derivatives
YU210773A (en) Process for obtaining imidazoquinazolin-2-one derivatives
YU36505B (en) Process for obtaining morphinone derivatives
HU171819B (hu) Sposob poluchenija proizvodnykh slozhnykh di-efirov 2-okso-3-fenoksi propil-fosfonnojj kisloty s alkanolami
YU36013B (en) Process for obtaining alfa-aryl-4-substituted piperidinoalkanol derivatives
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
YU310573A (en) Process for obtaining 3-hydroxycephalosporins
YU296173A (en) Process for obtaining new alkylthiocyclopentanone derivatives
YU35775B (en) Process for obtaining d-homosteroids
HU172069B (hu) Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov
YU332373A (en) Process for obtaining pregnanic acid derivatives
YU299479A (en) Process for obtaining novel aminoimidazoloisoquinoline derivatives
HU171818B (hu) Sposob poluchenija slozhnykh p-difenil-ehfirnykh proizvodnykh omega-arili oksa-prostaglandina
YU35776B (en) Process for obtaining quaternary bis-piperazine-androstane derivatives
YU98273A (en) Process for obtaining isopropylamines
HU167876B (en) Process for producing 9-10-secoestrane derivatives
HU173381B (hu) Sposob poluchenija proizvodnykh karboksi-ciklopropanov
CH613977A5 (en) Process for preparing tricyclohexyl-tin derivatives
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU146973A (en) Process for obtaining oxo-prostaglandins
YU35598B (en) Process for obtaining novel 1-acyl-homo-pyrimidazole derivatives
YU35253B (en) Process for preparing 2-imidazolidione derivatives
YU36972B (en) Process for obtaining 7-acylamido-7-alkoxycephalosporins